Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Using neurohormones to control keratin can lead to new skin disease treatments.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The environment around melanocyte stem cells is key for hair regeneration and color, with certain injuries affecting hair color and potential treatments for pigmentation disorders.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Recent advances in hair loss treatments show significant progress.

Substance from human umbilical cord blood cells promotes hair growth.

XEDAR triggers a specific signaling pathway in cells.

Mice with autoimmune hair loss showed signs of heart problems.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.